Search Results 821-830 of 18405 for prednisone

  1. A Study to Analyze CMP-001 in Combination With Nivolumab in Subjects With Advanced Melanoma - Mayo Clinic

    ... prednisone within 30 days before first dose of study treatment on W1D1. Subjects who are currently receiving steroids at a prednisone-equivalent dose of ...

  2. Broken ribs - Diagnosis and treatment - Mayo Clinic

    Diagnosis. During the physical exam, a health care provider might press gently on the ribs, listen to your lungs and watch your rib cage move as you breathe ...

  3. A Study to Assess the Aria CV Pulmonary Hypertension System to Treat Pulmonary Arterial Hypertension - Mayo Clinic

    ... Prednisone at a dose \> 12 mg per day at time of enrollment; ii. Excluded if any immunosuppressant other than Mycophenolate mofetil, Rituximab or Prednisone ...

  4. Aldesleukin (intravenous route) - Side effects & uses - Mayo Clinic

    Ebola Zaire Vaccine, Live; Hydrocortisone; Influenza Virus Vaccine, Live; Methylprednisolone; Paramethasone; Prednisolone; Prednisone; Rotavirus Vaccine, Live ...

  5. (Summit) A Study to Evaluate the Efficacy and Safety of CGT9486 Versus Placebo in Patients With Indolent or Smoldering Systemic Mastocytosis - Mayo Clinic

    Eastern Cooperative Oncology Group (ECOG) Performance Status 0 to 2. For patients receiving corticosteroids, the dose must be ≤ 10 mg/day of prednisone or ...

  6. Symptoms and causes - Mayo Clinic

    Long-term use of corticosteroid medicines, such as prednisone and cortisone, interferes with the bone-rebuilding process. These medicines are taken by mouth ...

  7. Oncology (Medical) - Clinical trials

    ... prednisone, thioguanine, vincristine, and pegaspargase work in different ways to stop the growth of cancer cells, either by killing the cells, by stopping ...

  8. Study of Pembrolizumab (MK-3475) Combination Therapies in Metastatic Castration-Resistant Prostate Cancer (MK-3475-365/KEYNOTE-365) - Mayo Clinic

    ... prednisone, and Cohort C will receive pembrolizumab + enzalutamide. Outcome measures will be assessed individually for each cohort. Participation ...

  9. A Study to Evaluate Response Markers to Treat Rheumatoid Arthritis - Mayo Clinic

    Prednisone dose > 15mg per day within 7 days of blood draw. Participating Mayo Clinic locations. Study statuses change often. Please contact the study team ...

  10. A Study to Evaluate the Safety, Tolerance and Anti-tumor Activity of SAR442257 in Patients with Relapsed/Refractory Multiple Myeloma and Relapsed/Refractory Non-Hodgkin Lymphoma - Mayo Clinic

    ... prednisone 10 mg daily. Clinically-not controlled chronic or ongoing infectious disease requiring treatment at the time of first dose or within the 14 days ...